NYSEAMERICAN:ELMD - Electromed Stock Price, Forecast & News

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

Electromed, Inc. (NYSEAMERICAN:ELMD) posted its earnings results on Tuesday, February, 11th. The medical equipment provider reported $0.14 EPS for the quarter, beating the Zacks' consensus estimate of $0.04 by $0.10. The medical equipment provider had revenue of $8.55 million for the quarter. View Electromed's Earnings History.

Electromed is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Electromed.

1 analysts have issued 12-month price targets for Electromed's shares. Their forecasts range from $12.00 to $12.00. On average, they anticipate Electromed's stock price to reach $12.00 in the next twelve months. This suggests that the stock has a possible downside of 3.8%. View Analyst Price Targets for Electromed.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Electromed.

News stories about ELMD stock have trended very positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Electromed earned a media sentiment score of 3.1 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Electromed.

Electromed saw a decrease in short interest in January. As of January 31st, there was short interest totalling 11,400 shares, a decrease of 58.2% from the January 15th total of 27,300 shares. Based on an average trading volume of 38,600 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.2% of the company's stock are sold short. View Electromed's Current Options Chain.

Some companies that are related to Electromed include Draegerwerk AG & Co KGaA (DRW3), Zynex (ZYXI), Creo Medical Group (CREO), Medica Group (MGP), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Hamilton Thorne (HTL), Advanced Oncotherapy (AVO), Cyclopharm (CYC), MRI Interventions (MRIC), Kromek Group (KMK), Patient Home Monitoring (PTQ), REVA Medical (RVA), Impedimed (IPD), EMvision Medical Devices (EMV) and Protech Home Medical (PHM).

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include NovaBay Pharmaceuticals (NBY), TransEnterix (TRXC), Rigel Pharmaceuticals (RIGL), TherapeuticsMD (TXMD), Akari Therapeutics (AKTX), Biocept (BIOC), Catalyst Pharmaceuticals (CPRX), Cytokinetics (CYTK), Amicus Therapeutics (FOLD) and Lexicon Pharmaceuticals (LXRX).

Electromed's stock is owned by a number of of retail and institutional investors. Top institutional investors include Tocqueville Asset Management L.P. (5.11%), Renaissance Technologies LLC (2.55%), Punch & Associates Investment Management Inc. (1.32%), EAM Investors LLC (1.18%), Gabelli Funds LLC (0.85%) and Acadian Asset Management LLC (0.65%). View Institutional Ownership Trends for Electromed.

ELMD stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, Punch & Associates Investment Management Inc., Tocqueville Asset Management L.P. and Creative Planning. View Insider Buying and Selling for Electromed.

ELMD stock was bought by a variety of institutional investors in the last quarter, including EAM Investors LLC, Renaissance Technologies LLC, Acadian Asset Management LLC, Advisory Services Network LLC and Geode Capital Management LLC. View Insider Buying and Selling for Electromed.

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ELMD stock can currently be purchased for approximately $12.48.

Electromed has a market capitalization of $105.81 million. Electromed employs 132 workers across the globe.View Additional Information About Electromed.

The official website for Electromed is http://smartvest.com/.

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.